Notably, in Mdm2+/−Arf+/−p53+/− mice, there was a decreased percentage of sarcomas and an increased percentage of carcinomas as compared to Mdm2+/+Arf+/−p53+/− mice. The gene discussed is CDKN2A; the disease is sarcoma.